MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN - 2 - X-RAY CRYSTALLOGRAPHIC ANALYSES OF PENICILLOPEPSIN COMPLEXED WITH A P3-P1 MACROCYCLIC PEPTIDYL INHIBITOR AND WITH ITS 2 ACYCLIC ANALOGS
Jh. Ding et al., MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN - 2 - X-RAY CRYSTALLOGRAPHIC ANALYSES OF PENICILLOPEPSIN COMPLEXED WITH A P3-P1 MACROCYCLIC PEPTIDYL INHIBITOR AND WITH ITS 2 ACYCLIC ANALOGS, Journal of the American Chemical Society, 120(19), 1998, pp. 4610-4621
Macrocyclic inhibitor 1 )phosphinyloxyethyl]-1-naphthaleneacetamide]so
dium salt} was designed according to the conformation of the acyclic a
nalogue Iva-L-Val-L-Val-L-Leu(P)-(O)Phe-OMe [Leu(P) = the phosphinic a
cid and analogue of L-leucine; (O)Phe = L-3-phenyllactic acid; OMe = m
ethyl ester] (4) bound to penicillopepsin, by linking the P1 and P3 si
de chains of the penicillopepsin inhibitor. This compound and its two
acyclic derivatives, yl)ethyl)hydroxyphosphinyloxy]-3-phenylpropanoate
, sodium salt} (2) and nomethyl)hydroxyphosphinyloxy]-3-phenylpropanoa
te, sodium salt} (3), have been synthesized and evaluated as inhibitor
s of penicillopepsin. Their binding affinity to the enzyme was found t
o be inversely related to the predicted degree of conformational flexi
bility across the series: 3 (K-i = 110 mu M), 2 (K-i = 7.6 mu M), 1 (K
-i = 0.8 mu M). The X-ray crystallographic structures of penicillopeps
in complexed with the macrocyclic peptidyl phosphonate 1 and with its
two derivatives 2 and 3 have been determined and refined to crystallog
raphic agreement factors R (=Sigma\\F-o\ - \F-c\\/Sigma\F-o\) of 15.9%
, 16.0%, and 15.2% and R-free of 19.8%, 20.3%, and 21.4%, respectively
. The intensity data for all complexes were collected to 1.5 Angstrom
resolution. One 1.25 Angstrom resolution data set was obtained for the
complex with 1 at 110 K; the structure was refined to an R factor of
15.0% (R-free of 19.7%) The binding interactions that 1 and 2 make wit
h penicillopepsin are similar to those that have been observed for oth
er transition-state mimics with aspartyl proteinases. On the other han
d, the acyclic Linear inhibitor 3 exhibits distinctive binding to peni
cillopepsin with the phosphonate group shifted similar to 3.0 Angstrom
from the average position observed for the other complexes. These str
uctural results show that the macrocyclic constraint of 1 enhances its
binding affinity over those of the acyclic analogues but the differen
ces in the observed bound dispositions mean that the effect has yet to
be quantified.